JP2009526861A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526861A5
JP2009526861A5 JP2008555380A JP2008555380A JP2009526861A5 JP 2009526861 A5 JP2009526861 A5 JP 2009526861A5 JP 2008555380 A JP2008555380 A JP 2008555380A JP 2008555380 A JP2008555380 A JP 2008555380A JP 2009526861 A5 JP2009526861 A5 JP 2009526861A5
Authority
JP
Japan
Prior art keywords
seq
lec3
ednra
cxcr4
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008555380A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526861A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/004114 external-priority patent/WO2007095353A2/en
Publication of JP2009526861A publication Critical patent/JP2009526861A/ja
Publication of JP2009526861A5 publication Critical patent/JP2009526861A5/ja
Pending legal-status Critical Current

Links

JP2008555380A 2006-02-14 2007-02-14 血管新生標的としてのｇｐｃｒ Pending JP2009526861A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77299106P 2006-02-14 2006-02-14
PCT/US2007/004114 WO2007095353A2 (en) 2006-02-14 2007-02-14 Gpcrs as angiogenesis targets

Publications (2)

Publication Number Publication Date
JP2009526861A JP2009526861A (ja) 2009-07-23
JP2009526861A5 true JP2009526861A5 (enExample) 2010-04-02

Family

ID=38372149

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008555380A Pending JP2009526861A (ja) 2006-02-14 2007-02-14 血管新生標的としてのｇｐｃｒ

Country Status (3)

Country Link
EP (1) EP1996619A4 (enExample)
JP (1) JP2009526861A (enExample)
WO (1) WO2007095353A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2822924T3 (es) 2014-09-26 2021-05-05 Helixmith Co Ltd Composición para prevenir o tratar una enfermedad arterial periférica utilizando el factor de crecimiento de hepatocitos y el factor 1a derivado de células del estroma
FR3077574B1 (fr) * 2018-02-07 2022-04-01 Commissariat Energie Atomique Anticorps dirige contre le sous-type a des recepteurs aux endothelines et ses utilisations.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759804A (en) * 1992-11-17 1998-06-02 Icos Corporation Isolated nucleic acid encoding seven transmembrane receptors
US6197578B1 (en) * 1996-01-30 2001-03-06 The United States Of America As Represented By The Department Of Health And Human Services Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infection
US6479256B1 (en) * 1998-03-04 2002-11-12 Icos Corporation Lectomedin materials and methods
JP2002506830A (ja) * 1998-03-13 2002-03-05 ザ ユニバーシティ オブ ブリティッシュ コロンビア 治療的ケモカイン受容体アンタゴニスト
US20020107195A1 (en) * 1998-07-21 2002-08-08 Smithkline Beecham Corporation Method for inducing chemotaxis in endothelial cells by administering stromal cell derived factor-1alpha
CA2438030A1 (en) * 2001-02-14 2002-10-10 Protein Design Labs Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
US20040009171A1 (en) * 2001-10-18 2004-01-15 Genentech, Inc. Methods for the treatment of carcinoma

Similar Documents

Publication Publication Date Title
ES2363162T3 (es) Composicones y procedimientos para el tratamiento de trastornos fibróticos.
RU2411042C2 (ru) Композиции и способы для лечения острого респираторного синдрома (sars)
EP3555122B1 (en) Decoy cytokine receptor
CN116063401B (zh) 阻断型靶向pd-l1的超高亲和力小蛋白及用途
EP1793856A2 (en) Methods and compositions for treating allergic inflammation
JPH06506596A (ja) インターロイキン−８受容体及び関連分子及び方法
WO2008103849A4 (en) Methods and compounds for lymphoma cell detection and isolation
JP2004536585A5 (enExample)
WO2013072901A2 (en) Compositions and methods for treating glioma
US6689878B2 (en) Target of RNAIII activating protein (TRAP)
JP2008517900A5 (enExample)
CN114686429B (zh) 一种激活nk细胞的肿瘤免疫治疗方法
KR20190123934A (ko) 신규한 중증열성혈소판감소증후군 바이러스
CZ2003947A3 (cs) Zkrácený a mutovaný lidský chemokin
JP2009526861A5 (enExample)
EP2988773A2 (en) Par-4 antagonists for use in the treatment or prevention of influenza virus type a infections
CN105143256A (zh) 血管生成素-2特异性Tie2受体
US11117976B2 (en) Compositions and methods for regulating erythropoiesis
US20080194467A1 (en) Cancer treatment methods using cadherin antagonists in combination with anticancer agents
CN116253775B (zh) 靶向抑制slug转录激活作用的多肽及其用途
US20160031937A1 (en) Neural regeneration peptides and uses therefor
CN117683094A (zh) 一种硬骨素结合环肽及其应用
JP2008504248A5 (enExample)
EP1188831B1 (en) Target of RNAIII activating protein (TRAP)
KR20200005165A (ko) 신규한 중증열성혈소판감소증후군 바이러스